Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007.

Global strategic partnerships in regenerative medicine.

Author information

1
The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK. Electronic address: anna.french@casmi.org.uk.
2
Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA.
3
Department of Genetics, Yale University, New Haven, CT 06520, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT 06520, USA; Yale Stem Cell Center, CT, 06520, USA.
4
Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
5
The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK.
6
Sartorius Stedim, Göttingen, 37079, Germany.
7
Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
8
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, Oxford, OX3 7LD, UK; The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA; Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, WC1N 1AX, UK.

Abstract

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.

KEYWORDS:

cell therapies; regenerative medicine; stem cells; strategic partnerships; translation

PMID:
25150363
DOI:
10.1016/j.tibtech.2014.05.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center